Progress & Promise: Breakthroughs in Cancer Research

Every breakthrough in cancer treatment brings us closer to better survival rates, earlier detection, and more effective therapies. In honor of World Cancer Day, we’re highlighting significant cancer research milestones of the past five years, plus the innovations poised to shape the future of oncology.

Download this infographic to discover:

  • Game-Changing Treatments: From the first CAR T-cell therapy for solid tumors to over 40 FDA approvals for immune checkpoint inhibitors like Keytruda.
  • Cutting-Edge Diagnostics: The rise of liquid biopsies and AI-powered imaging for earlier and more accurate cancer detection.
  • The Next Frontier in Cancer Care: mRNA cancer vaccines, gene editing (CRISPR-Cas9), and next-gen immunotherapies revolutionizing personalized medicine.

Cancer research is moving faster than ever, with precision medicine, artificial intelligence, and new therapies giving patients better outcomes and more treatment options. Interested in learning more? Read our blog World Cancer Day 2025: Reflecting on Research Milestones and Future Promises for in-depth insights into cancer research.

Learn more about our related services and resources:

TFS Oncology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology Expertise

Sarcoma
Up to 1 in 3 sarcoma diagnoses change on second reviewArticle

Up to 1 in 3 sarcoma diagnoses change on second review

TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.
The new endpoints reshaping oncology trial designWebinars

The new endpoints reshaping oncology trial design

The endpoint and eligibility shifts reshaping oncology trial design in 2026. Watch the full replay or download the slides.
RWD
Getting real-world evidence to the sponsor before the deadline, not afterCase Study

Getting real-world evidence to the sponsor before the deadline, not after

When a tight oncology RWE deadline moved forward by 10 days, TFS HealthScience restructured the team and delivered. Download the case study to find out how.